The Cost Of Caution In Clinical Trial Participant Support

When a participant can't afford to pay for a flight upfront, or needs childcare to get through a long study visit, the study may be able to help. But uncertainty about federal fraud and abuse rules often stops sponsors and research institutions from approving that support. What follows is overly cautious payment policies, reasonable support programs that never get started, and participants left paying costs the trial itself created.
Learn about Scout's recent public comment to the HHS Office of Inspector General (OIG) on the federal rules meant to prevent improper payments to patients. It explains why reimbursement, direct booking, payment for time, and incentives each serve a different purpose and deserve different levels of scrutiny. It also shows why reimbursement-only models and fixed spending caps can guard against real risks. See how clearer federal protections and better coordination across agencies could help your organization offer fair participant support with confidence, so that joining a study never depends on what someone can afford to pay upfront.
Get unlimited access to:
Enter your credentials below to log in. Not yet a member of Clinical Leader? Subscribe today.